Principal Financial Group Inc Revolution Medicines, Inc. Transaction History

Principal Financial Group Inc

  • $176 Billion
  • Q2 2025

A detailed history of Principal Financial Group Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 69,445 shares of RVMD stock, worth $3.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,445
Previous 12,792 442.88%
Holding current value
$3.45 Million
Previous $452,000 465.04%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
BUY
$31.13 - $41.98 $1.76 Million - $2.38 Million
56,653 Added 442.88%
69,445 $2.55 Million
Q1 2025

Apr 28, 2025
BUY
$35.36 - $44.42 $9,158 - $11,504
259 Added 2.07%
12,792 $452,000
Q4 2024

Jan 31, 2025
BUY
$42.97 - $60.6 $538,543 - $759,499
12,533 New
12,533 $548,000
Q3 2024

Oct 31, 2024
SELL
$36.92 - $47.94 $416,273 - $540,523
-11,275 Reduced 46.55%
12,947 $586,000
Q2 2024

Jul 29, 2024
SELL
$30.14 - $40.68 $180,990 - $244,283
-6,005 Reduced 19.87%
24,222 $940,000
Q1 2024

Apr 29, 2024
BUY
$26.56 - $33.55 $876 - $1,107
33 Added 0.11%
30,227 $974,000
Q4 2023

Feb 07, 2024
BUY
$18.35 - $34.12 $103,016 - $191,549
5,614 Added 22.84%
30,194 $865,000
Q3 2023

Nov 02, 2023
SELL
$25.17 - $35.05 $18,877 - $26,287
-750 Reduced 2.96%
24,580 $680,000
Q2 2023

Aug 07, 2023
BUY
$20.28 - $27.0 $56,236 - $74,871
2,773 Added 12.29%
25,330 $677,000
Q1 2023

May 09, 2023
BUY
$20.76 - $30.09 $78,597 - $113,920
3,786 Added 20.17%
22,557 $488,000
Q4 2022

Feb 09, 2023
BUY
$17.68 - $25.53 $37,110 - $53,587
2,099 Added 12.59%
18,771 $447,000
Q3 2022

Nov 09, 2022
BUY
$17.46 - $26.0 $71,271 - $106,132
4,082 Added 32.42%
16,672 $329,000
Q2 2022

Aug 10, 2022
BUY
$14.54 - $27.17 $61,867 - $115,608
4,255 Added 51.05%
12,590 $245,000
Q1 2022

May 09, 2022
SELL
$17.31 - $26.4 $8,135 - $12,408
-470 Reduced 5.34%
8,335 $213,000
Q4 2021

Feb 09, 2022
SELL
$24.35 - $33.7 $134,752 - $186,495
-5,534 Reduced 38.59%
8,805 $222,000
Q3 2021

Nov 09, 2021
SELL
$23.95 - $33.41 $228,722 - $319,065
-9,550 Reduced 39.98%
14,339 $394,000
Q2 2021

Aug 10, 2021
BUY
$29.0 - $47.44 $3,712 - $6,072
128 Added 0.54%
23,889 $758,000
Q1 2021

May 10, 2021
BUY
$37.21 - $54.43 $13,916 - $20,356
374 Added 1.6%
23,761 $1.09 Million
Q4 2020

Feb 08, 2021
BUY
$30.19 - $45.49 $530,287 - $799,031
17,565 Added 301.7%
23,387 $926,000
Q3 2020

Nov 06, 2020
BUY
$22.61 - $34.8 $131,635 - $202,605
5,822 New
5,822 $202,000

Others Institutions Holding RVMD

# of Institutions
334
Shares Held
195M
Call Options Held
908K
Put Options Held
723K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.36B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email